TABLE 2.
Parameters | YouTube | TikTok | p value |
---|---|---|---|
Discussion of high‐risk groups, n (%) | |||
High‐risk race/ethnicity | 23 (46) | 4 (8.0) | <0.001 |
Age‐specific recommendations | 27 (54) | 5 (10) | <0.001 |
Family history recommendations | 25 (50) | 3 (6) | <0.001 |
Discussion of additional screening tools, n (%) | |||
Digital rectal exam | 17 (34) | 7 (14) | 0.02 |
PSA testing | 48 (96) | 7 (14) | <0.001 |
MRI screening | 6 (12) | 0 (0) | 0.01 |
Prostate biopsy | 5 (10) | 0 (0) | 0.02 |
Genetic testing | 5 (10) | 0 (0) | 0.02 |
Video quality, n (%) | |||
DISCERN risks score ≥4 | 11 (22) | 0 (0) | <0.001 |
DISCERN benefits score ≥4 | 10 (20) | 0 (0) | <0.001 |
DISCERN shared decision‐making score ≥4 | 14 (28) | 0 (0) | <0.001 |
DISCERN high‐quality determination score ≥4 | 3 (6) | 0 (0) | 0.08 |
PEMAT understandability score ≥75% | 13 (26) | 1 (2) | <0.001 |
PEMAT actionability score ≥75% | 11 (22) | 0 (0) | <0.001 |
Accuracy of content | |||
Mean AUA Likert, score ± SD | 2.293 ± 0.913 | 1.113 ± 0.354 | <0.001 |
Mean NCCN Likert, score ± SD | 2.140 ± 0.873 | 1.107 ± 0.333 | <0.001 |
Mean Likert score ≥4, n (%) | 6 (12) | 0 (0) | 0.01 |
Abbreviations: AUA, American Urological Association; NCCN, National Comprehensive Cancer Network; PEMAT, Patient Education Materials Assessment Tool; PSA, prostate‐specific antigen.